Ventilator Associated Pneumonia (VAP) Bundles

Ventilator Associated Pneumonia Karissa Ellison George Washington University Ventilator Associated Pneumonia Introduction Ventilator Associated Pneumonia (VAP) is defined as pneumonia in a patient who is intubated and ventilated at the time of the onset of the event or 48 hours before, and VAP rate as the number of ventilator-associated pneumonias per 1,000 ventilator days (Institute for Healthcare Improvement, 2014a). The Institute for Healthcare Improvement (IHI) gives the following example

Running head: VENTILATOR-ASSOCIATED PNEUMONIA Ventilator-Associated Pneumonia (VAP): The Key to Prevention Aleisha N. Curry Professional Role Development II Nursing 402 Christian Brothers University February 20, 2012 Sue Trzynka, Ph.D., RN Introduction In the fast paced Trauma Intensive Care Unit (TICU) there are many things to remember while working with ventilated patients. Therefore, it is essential to implement practices that will decrease opportunities for

Annotated Bibliographies-VAP bundle Parisi, M. (2016). Use of Ventilator Bundle and Staff Education to Decrease Ventilator-Associated Pneumonia in Intensive Care Patients. Critical Care Nurse, 36(5), e1-e7. doi:10.4037/ccn2016520 Access path: I found this article using UWF library database using the words “ventilator-associated pneumonia” and “VAP bundle.” Title's information: The title of the article gives pertinent information about the content of the article. The study was done in the critical

Ventilator associated pneumonia (VAP) is a nosocomial infection occurring in hospitalized patients who are mechanically ventilated. These infections are common in ICU settings, difficult to diagnose early, and unfortunately have a high rate of mortality and morbidity. VAP accounts for almost half of infections in ICU settings, up to 28% of mechanically ventilated patients will develop VAP and of these patients the mortality rate is between 20% and 70% (Craven & Steger, 1998). A patient that develops

Prevention of Ventilator Associated Pneumonia Abstract Ventilator associated pneumonia (VAP) is a hospital acquired infection occurs in the intensive care unit (ICU) for the patients who are on mechanical ventilator. It further complicates the hospital course by extending the length of stay, increase the cost of treatment, and increases the mortality rate. It is estimated that about 1% to 3% patients on mechanical ventilator develops VAP per day. Compared to the previous years, the Chlorhexidine

Subglottic Suctioning: Preventing Ventilator Associated Pneumonia Ventilator Associated Pneumonia (VAP) is a hospital acquired infection which happens to patients who are intubated. It costs the hospital and the patient money. It is a deadly disease that can be prevented through the right type of interventions. Current practice generally depends on the hospital; most hospitals use a VAP bundle. According to the Institute for Healthcare Improvement (2012) the VAP bundle consists of; head of the bed elevation

will discuss the prevention of ventilator associated pneumonia utilizing the ventilator associated pneumonia care bundle and the impact it has on clinical practice. Topics that will also be discussed include potential barriers that may arise during the implementation of the bundle strategies, how they can be overcome and finally educational strategies for families. According to Safer healthcare now (2012), “Ventilator-associated pneumonia (VAP) is defined as a pneumonia occurring in patients requiring

“Ventilator -associated pneumonias are the leading cause of death for patients diagnosed with hospital acquired infections” (Sadeghi, Barzi, Mikhail, & Shabot, 2013, p. 223). Pneumonia rates are higher in mechanically ventilated patients because the artificial airway increases the opportunity for aspiration and colonization. The rate of VAP increases for patients ventilated more than three days resulting in length of stay in ICU and LOS after discharge from ICU (Sedwick, Lance-0Smith, Reeder, & Nardi

At this point this student has moved in the direction of reviewing studies based on ventilator associated pneumonia (VAP). Moreover, considering VAP bundles, with a detailed interest into their effectiveness both as a bundle and which accompanying parts may be more effective than others. VAP bundles have become a standard of care, and there is plenty of evidence which supports the need for them to be initiated. However, there are some studies that question their usefulness and categorically delve

Analysis Problem Statement In “Bundles to Prevent Ventilator-Associated Pneumonia: How valuable are they?,” Charity Wip and Lena Napolitano present the results of a qualitative study to determine the value of different care bundles in preventing the occurrence of ventilator-associated pneumonia (VAP). In fact, the authors concede that VAP is often resultant of the ventilator care plan, and that the ventilator bundle would be critical in reducing the occurrence of VAPs among the intensive care unit